AstraZeneca Logo for IRT page_v2

Science and Technology Theater

Saturday, October 17

New Data on ATTR-CM for Health Care Providers From CARDIO-TTRansform

Join an AstraZeneca- and Ionis-sponsored session presenting phase 3 trial results for an investigational treatment for transthyretin amyloid cardiomyopathy (ATTR- CM).
Speaker: Andrew Darlington, DO, FACC

Bracco SS

Presented by Northwest Imaging Forums, Inc.
Supported with an unrestricted educational grant provided by Bracco Diagnostics Inc.

Science & Technology Theater

Sunday, October 18

Clear Images, Confident Decisions: Ultrasound Enhancing Agents in Everyday Practice

This session will provide a practical overview of ultrasound enhancing agents (UEAs) and their role in everyday clinical practice. Participants will review key properties of UEAs, explore common clinical applications and considerations for determining when their use may enhance diagnostic imaging, and discuss important workflow and safety considerations. The session will emphasize practical strategies for integrating UEAs effectively and confidently into routine ultrasound practice.

Speaker: James P. MacNamara, MD

Loading...

Echo Florida Faculty

Loading...